During the second day of the U.S. Centers for Disease Control and Prevention (CDC) recent Advisory Committee on Immunization Practices (ACIP) meeting, influenza vaccines became the main focus.
As the current flu season comes to a close, the ACIP reported that the next round of influenza vaccines, which are scheduled to arrive in pharmacies in August 2024, will be different.
On June 27, 2024, the ACIP confirmed all influenza vaccines marketed in the U.S. for the 2024-25 flu season would be trivalent, not quadrivalent.
Fewer Flu Shots Distributed, Fewer Influenza Deaths Reported
Fewer Flu Shots Distributed, Fewer Influenza Deaths Reported
During the second day of the U.S. Centers for Disease Control and Prevention (CDC) recent Advisory Committee on Immunization Practices (ACIP) meeting, influenza vaccines became the main focus.
As the current flu season comes to a close, the ACIP reported that the next round of influenza vaccines, which are scheduled to arrive in pharmacies in August 2024, will be different.
On June 27, 2024, the ACIP confirmed all influenza vaccines marketed in the U.S. for the 2024-25 flu season would be trivalent, not quadrivalent.
New UTI Treatments Confirm Positive Advances in 2024
For the first time in decades, novel urinary tract infection (UTI) treatments and vaccines are making significant progress worldwide.
Recce Pharmaceuticals Ltd today announced positive data from a Phase I/II clinical trial for UTIs and urosepsis, demonstrating that RECCE® 327 (R327) administered intravenously is safe and efficacious against Escherichia coli (E. coli).
CDC Advises Updated COVID Vaccine for Everyone Over 6 Months of Age
By Robin Foster HealthDay ReporterFRIDAY, June 28, 2024 (HealthDay News) — As a summer wave of COVID infections rolls across the country, U.S. health officials have recommended that all Americans …
Ignorance Could Be Fueling Rising Spread of STDs, Poll Finds
By Dennis Thompson HealthDay ReporterTHURSDAY, June 27, 2024 (HealthDay News) — Many sexually transmitted diseases are on the rise in the United States, and a nationwide poll indicates that ignorance …
U.S. CDC Preps Vaccinations to Prevent Chikungunya Outbreaks
The most challenging travel-related disease to pronounce and spell, Chikungunya, may soon pose more significant risks for international travelers.
Wilbur Chen, MD, MS, who leads the Chikungunya Vaccines Work Group of the Advisory Committee on Immunization Practices (ACIP), today offered policy options to reduce the impact of future Chikungunya outbreaks.
Over 20% of the local population could be impacted when a Chikungunya outbreak occurs.
Dengue Vaccines Harder to Find in 2024
During the U.S. Centers for Disease Control and Prevention (CDC) vaccine committee meeting this afternoon, it will be mentioned that finding a dengue vaccine in 2024 poses a challenge for international travelers.
At 5 PM ET on June 26, 2024, the CDC's Advisory Committee on Immunization Practices (ACIP) meeting is scheduled to review two presentations that reveal the leading dengue vaccines are unavailable this year to U.S.-based international travelers.
Dengue Outbreak Alert Issued for the U.S.
According to the Centers for Disease Control and Prevention (CDC), the global incidence of dengue this year is the highest in recent history, with about 100 countries reporting higher-than-usual dengue case numbers.
For example, in the Region of the Americas, more than 9.7 million dengue cases have been reported this year, twice as many as in all of 2023.
COVID-19 Vaccination Not Tied to Adverse Pregnancy Outcomes
Findings for range of neonatal outcomes among individuals receiving vaccine during pregnancy
Cannabis Use Tied to Risk of COVID-19 Hospitalizations, ICU Admissions
Findings even after considering cigarette smoking, vaccination status, comorbidities, and other risk factors